Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

ClinicalTrials.gov ID: NCT00683137

Public ClinicalTrials.gov record NCT00683137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Protocol for a Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for Treatment of Post-Surgical Pain From Bunionectomy Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect of the 2 valdecoxib doses compared to placebo on health outcome measures and on the occurrence of opioid related symptoms.

Study identification

NCT ID
NCT00683137
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
450 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2002 (Type not available)
Primary completion
Not listed
Completion
Feb 2003 (Actual)
Last update posted
May 23, 2008

2002 – 2003

United States locations

U.S. sites
89
U.S. states
18
U.S. cities
53
Facility City State ZIP Site status
Pfizer Investigational Site Chandler Arizona 85224 —
Pfizer Investigational Site Glendale Arizona 85302 —
Pfizer Investigational Site Glendale Arizona 85306 —
Pfizer Investigational Site Mesa Arizona 85204 —
Pfizer Investigational Site Phoenix Arizona 58029 —
Pfizer Investigational Site Phoenix Arizona 85012 —
Pfizer Investigational Site Phoenix Arizona 85015 —
Pfizer Investigational Site Phoenix Arizona 85016 —
Pfizer Investigational Site Phoenix Arizona 85022 —
Pfizer Investigational Site Phoenix Arizona 85023 —
Pfizer Investigational Site National City California 91950 —
Pfizer Investigational Site San Diego California 91950 —
Pfizer Investigational Site San Diego California 92103 —
Pfizer Investigational Site San Diego California 92114 —
Pfizer Investigational Site San Diego California 92116 —
Pfizer Investigational Site Milford Connecticut 06460 —
Pfizer Investigational Site New Haven Connecticut 06515 —
Pfizer Investigational Site New Haven Connecticut 6515 —
Pfizer Investigational Site Cooper City Florida 33330 —
Pfizer Investigational Site Cutler Ridge Florida 33157 —
Pfizer Investigational Site Fort Lauderdale Florida 33306 —
Pfizer Investigational Site Fort Lauderdale Florida 33308 —
Pfizer Investigational Site Hallandale Florida 33009 —
Pfizer Investigational Site Hollywood Florida 33020 —
Pfizer Investigational Site Hollywood Florida 33021 —
Pfizer Investigational Site Miami Florida 33180 —
Pfizer Investigational Site New Port Richey Florida 34652 —
Pfizer Investigational Site New Port Richey Florida 34653 —
Pfizer Investigational Site New Port Richey Florida 34655 —
Pfizer Investigational Site Pembroke Pines Florida 33027 —
Pfizer Investigational Site Pembroke Pines Florida 33028 —
Pfizer Investigational Site Port Richey Florida 34668 —
Pfizer Investigational Site South Miami Florida 33143 —
Pfizer Investigational Site Spring Hill Florida 34608 —
Pfizer Investigational Site Addison Illinois 60101 —
Pfizer Investigational Site Elk Grove Village Illinois 60007 —
Pfizer Investigational Site Peoria Illinois 61602 —
Pfizer Investigational Site Peoria Illinois 61614 —
Pfizer Investigational Site Peoria Illinois 61615 —
Pfizer Investigational Site Evansville Indiana 47713 —
Pfizer Investigational Site New Orleans Louisiana 70127 —
Pfizer Investigational Site New Orleans Louisiana 70128 —
Pfizer Investigational Site Annapolis Maryland 21401 —
Pfizer Investigational Site Chester Maryland 21619 —
Pfizer Investigational Site Omaha Nebraska 68124 —
Pfizer Investigational Site Omaha Nebraska 68134 —
Pfizer Investigational Site Omaha Nebraska 68144 —
Pfizer Investigational Site Las Vegas Nevada 89102 —
Pfizer Investigational Site Las Vegas Nevada 89104 —
Pfizer Investigational Site Las Vegas Nevada 89106 —
Pfizer Investigational Site Las Vegas Nevada 89121 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Bismarck North Dakota 58501 —
Pfizer Investigational Site Austintown Ohio 44515 —
Pfizer Investigational Site Canfield Ohio 44406 —
Pfizer Investigational Site Cleveland Ohio 44106 —
Pfizer Investigational Site Youngstown Ohio 44512 —
Pfizer Investigational Site Youngstown Ohio 44515 —
Pfizer Investigational Site Portland Oregon 97205 —
Pfizer Investigational Site Altoona Pennsylvania 16602 —
Pfizer Investigational Site Altoona Pennsylvania — —
Pfizer Investigational Site Duncansville Pennsylvania 16635 —
Pfizer Investigational Site Havertown Pennsylvania 19083 —
Pfizer Investigational Site Media Pennsylvania 19063 —
Pfizer Investigational Site Philadelphia Pennsylvania 19107-2496 —
Pfizer Investigational Site Philadelphia Pennsylvania 19140 —
Pfizer Investigational Site Philadelphia Pennsylvania — —
Pfizer Investigational Site Reading Pennsylvania 19606 —
Pfizer Investigational Site State College Pennsylvania 16803 —
Pfizer Investigational Site Upland Pennsylvania 19013 —
Pfizer Investigational Site Wyomissig Pennsylvania 19610 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Austin Texas 78731 —
Pfizer Investigational Site Austin Texas 78756 —
Pfizer Investigational Site San Antonio Texas 78205 —
Pfizer Investigational Site San Antonio Texas 78209 —
Pfizer Investigational Site San Antonio Texas 78240 —
Pfizer Investigational Site San Antonio Texas — —
Pfizer Investigational Site Holladay Utah 84117 —
Pfizer Investigational Site Layton Utah 84041 —
Pfizer Investigational Site Provo Utah 84054 —
Pfizer Investigational Site Salt Lake City Utah 84102 —
Pfizer Investigational Site Salt Lake City Utah 84107 —
Pfizer Investigational Site Salt Lake City Utah 84117 —
Pfizer Investigational Site Salt Lake City Utah 84124 —
Pfizer Investigational Site Salt Lake City Utah 84157-0667 —
Pfizer Investigational Site Sandy City Utah 84070 —
Pfizer Investigational Site St. George Utah 84770 —
Pfizer Investigational Site Tacoma Washington 98431-5000 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00683137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2008 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00683137 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →